Business · 30/12/2016Updated: 10/17/2026 · 1 min read
FDA Extends Comment Period on Use of Term
Summary
The Food and Drug Administration (FDA) is extending the comment period for a docket to receive information and comments on the use of the term
Original source language: Federal Register — Food and Drug AdministrationOpen original release →